REQUEST A DEMO
Total
USD $0.00
Search more companies

Acta Pharma AD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Acta Pharma AD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Acta Pharma AD is a company based in Bulgaria, with its head office in Sofia. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Acta Pharma AD was incorporated on December 15, 2009. It currently has a total number of 52 (2023) employees. From the latest financial highlights, Acta Pharma AD reported a net sales revenue increase of 13% in 2022. Its’ total assets recorded a growth of 29.22%. In, 2022, the company’s net profit margin decreased by 0.5%.

Headquarters
zh.k. Ovcha Kupel 1, bl. 425, vh. B
Sofia; Sofia - city; Postal Code: 1632

Contact Details: Purchase the Acta Pharma AD report to view the information.

Basic Information
Total Employees:
Purchase the Acta Pharma AD report to view the information.
Outstanding Shares:
Purchase the Acta Pharma AD report to view the information.
Registered Capital:
Purchase the Acta Pharma AD report to view the information.
Incorporation Date:
December 15, 2009
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Acta Pharma AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
13%
Total operating revenue
13%
Net Profit (Loss) for the Period
1.33%
Total assets
29.22%
Total equity
26.41%
Net Profit Margin
-0.5%
Return on Equity (ROE)
-5.17%
Quick Ratio
-19.43%
Cash Ratio
0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?